Mountain Crest Acquisition Corp. II

If you purchased Mountain Crest Acquisition Corp. II securities and would like to join the action, please click "Join This Action" below.

MOUNTAIN CREST MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF MOUNTAIN CREST ACQUISITION CORP. II IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – MCAD

April 28, 2021.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) with Better Therapeutics, Inc. is fair to Mountain Crest shareholders.

The investigation concerns whether Mountain Crest and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Mountain Crest shareholders; and (2) disclose all material information necessary for Mountain Crest shareholders to adequately assess and value the merger consideration.

On behalf of Mountain Crest shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Scroll to Top